19.8
88.7 %
96.5 %
Indicators in the Citation impact, Journal impact and Co‑publishing tabs are based on Web of Science publications only. Corresponding Scopus indicators can be found under the Scopus tab.
Overall Web of Science coverage for peer reviewed publications in this unit is good, 88.7%.
Note that the coverage numbers for Web of Science and Scopus apply to publications in the KTH bibliometric database Bibmet. If a WoS-id or Scoupus-id from DiVA can not be matched in Bibmet, it does not count as covered.
The bibliometric indicators referred are based on publications registered in DiVA. Only publications from currently employed researchers at KTH are included. The rolling nature of this report means that it provides more of a current overview and less of a historic stable trend, since it excludes publications written by researchers that are no longer affiliated to KTH, but have been at some point in time.
Indicators in the Citation impact, Journal impact and Co‑publishing tabs are based on Web of Science publications only. Corresponding Scopus indicators can be found under the Scopus tab.
Publication data is available only after login.
| DiVA publication type | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Publications | WoS coverage | Scopus coverage |
|---|---|---|---|---|---|---|---|---|---|---|
| Article, peer review | 6.6 | 5.2 | 4.8 | 5.9 | 10.3 | 11.8 | 11.9 | 56.4 | 94.8% | 1.0 |
| Article, other | NA | 1.1 | NA | 0.5 | 0.3 | 0.2 | 0.8 | 2.9 | 88.5% | 1.0 |
| Conference paper, peer review | 4.3 | 5.6 | 3.8 | 11.1 | 12.8 | 12.3 | 4.2 | 54.0 | 82.4% | 1.0 |
| Conference paper, other | 1.9 | 2.1 | 1.1 | 2.3 | 5.2 | 0.5 | 1.6 | 14.7 | 4.0% | 0.2 |
| Chapter in book | NA | 0.3 | 1.0 | NA | NA | NA | NA | 1.3 | 0.0% | 1.0 |
| Article, book review | NA | 0.6 | NA | NA | NA | NA | NA | 0.6 | 100.0% | 1.0 |
| Report | NA | NA | NA | NA | 0.2 | NA | NA | 0.2 | 0.0% | 0.0 |
| Doctoral thesis | 1.0 | NA | NA | 1.0 | 2.0 | NA | NA | 4.0 | 0.0% | 0.0 |
| Patent | NA | NA | NA | NA | 0.3 | 1.7 | 1.2 | 3.2 | 0.0% | 0.0 |
| DiVA publication type | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Publications | WoS coverage | Scopus coverage |
|---|---|---|---|---|---|---|---|---|---|---|
| Article, peer review | 15 | 15 | 15 | 21 | 29 | 35 | 40 | 170 | 95.3% | 1 |
| Article, other | NA | 2 | NA | 2 | 1 | 1 | 2 | 8 | 87.5% | 1 |
| Conference paper, peer review | 11 | 14 | 9 | 25 | 24 | 23 | 9 | 115 | 80.9% | 1 |
| Conference paper, other | 8 | 5 | 3 | 5 | 10 | 2 | 5 | 38 | 10.5% | 0 |
| Chapter in book | NA | 1 | 2 | NA | NA | NA | NA | 3 | 0.0% | 1 |
| Article, book review | NA | 1 | NA | NA | NA | NA | NA | 1 | 100.0% | 1 |
| Report | NA | NA | NA | NA | 1 | NA | NA | 1 | 0.0% | 0 |
| Doctoral thesis | 1 | NA | NA | 1 | 2 | NA | NA | 4 | 0.0% | 0 |
| Patent | NA | NA | NA | NA | 1 | 3 | 2 | 6 | 0.0% | 0 |
| Publication Year | Publications | Total Citations | Average Citations | Uncited publications | Share uncited |
|---|---|---|---|---|---|
| 2014 | 9.6 | 11.2 | 1.2 | 3.7 | 38.4% |
| 2015 | 11.6 | 65.4 | 5.6 | 5.1 | 44.2% |
| 2016 | 8.2 | 25.9 | 3.2 | 2.3 | 27.7% |
| 2017 | 16.1 | 43.5 | 2.7 | 8.6 | 53.2% |
| 2018 | 20.7 | 96.8 | 4.7 | 8.1 | 39.2% |
| Total | 66.3 | 242.7 | 3.7 | 27.8 | 41.9% |
| Publication years | Publications | Average Cf | Top 10% publications | Share Top 10% |
|---|---|---|---|---|
| 2014-2016 | 16.7 | 0.86 | 2.1 | 12.4% |
| 2015-2017 | 16.3 | 1.11 | 2.5 | 15.2% |
| 2016-2018 | 20.7 | 0.99 | 2.2 | 10.5% |
| 2017-2019 | 27.4 | 1.06 | 2.3 | 8.2% |
| Total | 44.2 | 0.99 | 4.3 | 9.8% |
This table is based on Web of Science publication types Article, Proceedings paper, Review, Letter and Editorial.
Rows are based on at least 23 (full counted) publications with good Web of Science coverage (at least 87.7%).
(DiVA publication types Article, peer review and Conference paper, peer review)
Indicators based on < 50 publications are considered unreliable
This table is based on Web of Science publication types Article and Review.
Rows are based on at least 43 (full counted) publications with good Web of Science coverage (at least 93.5%).
(DiVA publication type Article, peer review)
Indicators based on < 50 publications are considered unreliable
| Publication years | Publications | Average Journal Cf | Publications in Top 20% journals | Share Top 20% journals |
|---|---|---|---|---|
| 2014-2016 | 16.1 | 1.16 | 2.6 | 16.2% |
| 2015-2017 | 15.5 | 1.27 | 3.5 | 22.5% |
| 2016-2018 | 20.5 | 1.78 | 9.5 | 46.3% |
| 2017-2019 | 27.2 | 1.78 | 12.5 | 45.9% |
| 2018-2020 | 32.6 | 1.75 | 15.6 | 47.8% |
| Total | 54.1 | 1.51 | 19.6 | 36.2% |
This table is based on Web of Science publication types Article and Review.
Rows are based on at least 43 (full counted) publications with good Web of Science coverage (at least 93.5%).
(DiVA publication type Article, peer review)
Indicators based on < 50 publications are considered unreliable
| Publication years | Publications | Swedish non-university co-publications | Share Swedish non-university | International co-publications | Share international |
|---|---|---|---|---|---|
| 2014-2016 | 44 | 12 | 27.3% | 16 | 36.4% |
| 2015-2017 | 51 | 11 | 21.6% | 24 | 47.1% |
| 2016-2018 | 64 | 12 | 18.8% | 34 | 53.1% |
| 2017-2019 | 82 | 17 | 20.7% | 47 | 57.3% |
| 2018-2020 | 99 | 23 | 23.2% | 61 | 61.6% |
| Total | 163 | 38 | 23.3% | 88 | 54.0% |
This table is based on Web of Science publication types Article and Review.
Rows are based on at least 44 (full counted) publications with good Web of Science coverage (at least 94.1%).
(DiVA publication type Article, peer review)
Indicators based on < 50 publications are considered unreliable
| Country | Publications | 1-10 auth | 11-50 auth | 51-200 auth | Over 200 auth | Publications (frac) |
|---|---|---|---|---|---|---|
| Germany | 30 | 22 | 7 | 1 | 0 | 8.8 |
| United States | 24 | 11 | 12 | 1 | 0 | 4.1 |
| United Kingdom | 19 | 12 | 7 | 0 | 0 | 3.7 |
| Switzerland | 15 | 10 | 5 | 0 | 0 | 3.1 |
| Belgium | 12 | 9 | 3 | 0 | 0 | 2.2 |
| Russian Federation | 5 | 5 | 0 | 0 | 0 | 1.9 |
| Poland | 2 | 2 | 0 | 0 | 0 | 1.6 |
| Italy | 6 | 3 | 3 | 0 | 0 | 1.2 |
| France | 4 | 4 | 0 | 0 | 0 | 1.2 |
| India | 6 | 5 | 1 | 0 | 0 | 1.2 |
| Finland | 5 | 4 | 1 | 0 | 0 | 1.1 |
| Netherlands | 3 | 2 | 1 | 0 | 0 | 1.1 |
| Israel | 8 | 4 | 3 | 1 | 0 | 1.0 |
| Australia | 4 | 1 | 3 | 0 | 0 | 0.9 |
| Norway | 3 | 2 | 1 | 0 | 0 | 0.9 |
| Austria | 3 | 2 | 1 | 0 | 0 | 0.9 |
| Spain | 6 | 3 | 3 | 0 | 0 | 0.8 |
| Japan | 3 | 3 | 0 | 0 | 0 | 0.8 |
| Turkey | 1 | 1 | 0 | 0 | 0 | 0.7 |
| Korea, Republic of | 3 | 1 | 2 | 0 | 0 | 0.6 |
| Ireland | 3 | 1 | 2 | 0 | 0 | 0.6 |
| China | 4 | 1 | 3 | 0 | 0 | 0.5 |
| Liechtenstein | 1 | 1 | 0 | 0 | 0 | 0.4 |
| Saudi Arabia | 4 | 0 | 4 | 0 | 0 | 0.4 |
| Canada | 3 | 2 | 1 | 0 | 0 | 0.4 |
| Iceland | 1 | 1 | 0 | 0 | 0 | 0.3 |
| Taiwan | 2 | 1 | 1 | 0 | 0 | 0.2 |
| Denmark | 4 | 0 | 4 | 0 | 0 | 0.2 |
| Iraq | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Portugal | 2 | 0 | 1 | 1 | 0 | 0.1 |
| Singapore | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Organization | Organization type | Country | Publications | 1-10 auth | 11-50 auth | 51-200 auth | Over 200 auth | Publications (frac) |
|---|---|---|---|---|---|---|---|---|
| Karolinska Institutet | University | Sweden | 29 | 19 | 10 | 0 | 0 | 7.2 |
| SenseAir AB | Company | Sweden | 9 | 9 | 0 | 0 | 0 | 4.0 |
| Karlsruhe Institute of Technology | University | Germany | 9 | 8 | 1 | 0 | 0 | 3.5 |
| Silex Microsystems AB | Company | Sweden | 9 | 8 | 1 | 0 | 0 | 3.4 |
| RWTH Aachen University | University | Germany | 9 | 7 | 2 | 0 | 0 | 3.3 |
| Swiss Federal Institute of Technology Lausanne (EPFL) | University | Switzerland | 12 | 8 | 4 | 0 | 0 | 2.8 |
| AMO GmbH | Institute | Germany | 6 | 5 | 1 | 0 | 0 | 2.4 |
| Uppsala University | University | Sweden | 9 | 7 | 2 | 0 | 0 | 2.2 |
| Karolinska University Hospital | University Hospital | Sweden | 8 | 6 | 2 | 0 | 0 | 2.0 |
| Chalmers University of Technology | University | Sweden | 8 | 5 | 3 | 0 | 0 | 1.7 |
| Polish Academy of Science | Other | Poland | 2 | 2 | 0 | 0 | 0 | 1.6 |
| Harvard University | University | United States | 13 | 1 | 11 | 1 | 0 | 1.4 |
| Ericsson | Company | Sweden | 5 | 3 | 2 | 0 | 0 | 1.3 |
| APR Technologies AB | Company | Sweden | 3 | 2 | 1 | 0 | 0 | 1.3 |
| University of Cambridge | University | United Kingdom | 5 | 5 | 0 | 0 | 0 | 1.1 |
| California Institute of Technology | University | United States | 4 | 4 | 0 | 0 | 0 | 1.1 |
| Mycronic | Company | Sweden | 3 | 3 | 0 | 0 | 0 | 1.1 |
| ITMO (Information Technologies, Mechanics and Optics) University | University | Russian Federation | 3 | 3 | 0 | 0 | 0 | 1.1 |
| University of Siegen | University | Germany | 5 | 3 | 2 | 0 | 0 | 1.1 |
| MyVox AB | Company | Sweden | 2 | 2 | 0 | 0 | 0 | 0.9 |
| Aalto University | University | Finland | 3 | 3 | 0 | 0 | 0 | 0.9 |
| Ghent University | University | Belgium | 4 | 2 | 2 | 0 | 0 | 0.9 |
| University of New South Wales | University | Australia | 3 | 1 | 2 | 0 | 0 | 0.9 |
| Russian Academy of Sciences | Other Public | Russian Federation | 2 | 2 | 0 | 0 | 0 | 0.8 |
| Politecnico di Milano | University | Italy | 1 | 1 | 0 | 0 | 0 | 0.8 |
| Vellore Institute of Technology (VIT) | University Other | India | 3 | 3 | 0 | 0 | 0 | 0.8 |
| University of Bristol | University | United Kingdom | 2 | 2 | 0 | 0 | 0 | 0.7 |
| Scania AB | Company | Sweden | 2 | 2 | 0 | 0 | 0 | 0.7 |
| Ege University | University | Turkey | 1 | 1 | 0 | 0 | 0 | 0.7 |
| Grenoble Institute of Technology | University | France | 1 | 1 | 0 | 0 | 0 | 0.7 |
| Keio University | University | Japan | 2 | 2 | 0 | 0 | 0 | 0.7 |
| University of Twente | University | Netherlands | 2 | 1 | 1 | 0 | 0 | 0.6 |
| IMEC | Institute | Belgium | 3 | 2 | 1 | 0 | 0 | 0.6 |
| AstraZeneca | Company | Sweden | 5 | 2 | 3 | 0 | 0 | 0.6 |
| Mercene Labs AB | Company | Sweden | 3 | 3 | 0 | 0 | 0 | 0.6 |
| California State University, Sacramento (CSUS) | University | United States | 1 | 1 | 0 | 0 | 0 | 0.6 |
| Saxion Univ Appl Sci | University | Netherlands | 1 | 1 | 0 | 0 | 0 | 0.6 |
| Umeå University | University | Sweden | 1 | 1 | 0 | 0 | 0 | 0.6 |
| Univ Appl Sci Campus Vienna | University | Austria | 1 | 1 | 0 | 0 | 0 | 0.6 |
| Imperial College London | University | United Kingdom | 3 | 0 | 3 | 0 | 0 | 0.6 |
| Indian Institutes of Technology | University | India | 3 | 3 | 0 | 0 | 0 | 0.6 |
| Loughborough University | University | United Kingdom | 4 | 4 | 0 | 0 | 0 | 0.5 |
| Tel Aviv University | University | Israel | 5 | 1 | 3 | 1 | 0 | 0.5 |
| Swedish Defence Research Agency | Institute | Sweden | 2 | 2 | 0 | 0 | 0 | 0.5 |
| University of Antwerp | University | Belgium | 2 | 2 | 0 | 0 | 0 | 0.5 |
| GWANGJU INSTITUTE OF SCIENCE & TECHNOLOGY | University | Korea, Republic of | 1 | 1 | 0 | 0 | 0 | 0.5 |
| University of Westminster | University | United Kingdom | 2 | 2 | 0 | 0 | 0 | 0.5 |
| Vironova AB | Company | Sweden | 1 | 1 | 0 | 0 | 0 | 0.5 |
| SINTEF | Institute | Norway | 2 | 1 | 1 | 0 | 0 | 0.5 |
| Ben-Gurion University of the Negev | University | Israel | 3 | 3 | 0 | 0 | 0 | 0.5 |
| Delft University of Technology | University | Netherlands | 1 | 1 | 0 | 0 | 0 | 0.4 |
| Micronitor AS | Company | Norway | 1 | 1 | 0 | 0 | 0 | 0.4 |
| Stockholms läns landsting | Other health services | Sweden | 1 | 1 | 0 | 0 | 0 | 0.4 |
| Volvo Car Corp | Company | Sweden | 1 | 1 | 0 | 0 | 0 | 0.4 |
| Sahlgrenska University Hospital | University Hospital | Sweden | 3 | 1 | 2 | 0 | 0 | 0.4 |
| Skövde University College | University College | Sweden | 3 | 1 | 2 | 0 | 0 | 0.4 |
| University College London | University | United Kingdom | 3 | 1 | 2 | 0 | 0 | 0.4 |
| University of Gothenburg | University | Sweden | 3 | 1 | 2 | 0 | 0 | 0.4 |
| Bundeswehr University Munich | University | Germany | 1 | 1 | 0 | 0 | 0 | 0.4 |
| Evatec AG | Company | Liechtenstein | 1 | 1 | 0 | 0 | 0 | 0.4 |
| Polytechnic University of Valencia (UPV) | University | Spain | 3 | 0 | 3 | 0 | 0 | 0.4 |
| IBM Corp | Company | Switzerland | 2 | 2 | 0 | 0 | 0 | 0.4 |
| RISE - Research Institutes of Sweden | Institute | Sweden | 3 | 2 | 1 | 0 | 0 | 0.4 |
| Linköping University | University | Sweden | 2 | 2 | 0 | 0 | 0 | 0.4 |
| University of California, Los Angeles | University | United States | 3 | 1 | 2 | 0 | 0 | 0.3 |
| Catholic University of Leuven | University | Belgium | 3 | 3 | 0 | 0 | 0 | 0.3 |
| Microsystem Technologies | Other | Germany | 1 | 1 | 0 | 0 | 0 | 0.3 |
| X-Fab | Company | Germany | 1 | 1 | 0 | 0 | 0 | 0.3 |
| Commscope | Company | Belgium | 2 | 0 | 2 | 0 | 0 | 0.3 |
| Tyndall National Institute | Institute | Ireland | 2 | 0 | 2 | 0 | 0 | 0.3 |
| Massachusetts Institute of Technology | University | United States | 6 | 0 | 6 | 0 | 0 | 0.3 |
| University of Rennes 1 | University | France | 2 | 2 | 0 | 0 | 0 | 0.3 |
| TE Connectivity | Company | Switzerland | 1 | 1 | 0 | 0 | 0 | 0.3 |
| University of Iceland | University | Iceland | 1 | 1 | 0 | 0 | 0 | 0.3 |
| University of Iceland | University | Ireland | 1 | 1 | 0 | 0 | 0 | 0.3 |
| University of Southampton | University | United Kingdom | 1 | 1 | 0 | 0 | 0 | 0.3 |
| Infineon Technologies | Company | Austria | 2 | 1 | 1 | 0 | 0 | 0.3 |
| Spanish National Research Council (CSIC) | Institute | Spain | 2 | 1 | 1 | 0 | 0 | 0.3 |
| University of Maryland, College Park | University | United States | 2 | 2 | 0 | 0 | 0 | 0.3 |
| NASA | Other Public | United States | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Spiber Technology AB | NA | Sweden | 1 | 1 | 0 | 0 | 0 | 0.2 |
| VIT | NA | India | 1 | 1 | 0 | 0 | 0 | 0.2 |
| University of Leicester | University | United Kingdom | 2 | 2 | 0 | 0 | 0 | 0.2 |
| Beihang University | University | China | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Chemnitz University of Technology | University | Germany | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Ctr Nano & Biophoton NB Photon | NA | Belgium | 1 | 1 | 0 | 0 | 0 | 0.2 |
| King Abdullah University of Science and Technology | University | Saudi Arabia | 2 | 0 | 2 | 0 | 0 | 0.2 |
| Boston Children’s Hospital | Other health services | United States | 5 | 0 | 4 | 1 | 0 | 0.2 |
| Bioengineering, Biomaterials and Nanomedicine Networking Biomedical Research Centre (CIBER-BBN) | Institute | Spain | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Cedars-Sinai | Other health services | United States | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Stockholm University | University | Sweden | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Université de Montréal | University | Canada | 1 | 1 | 0 | 0 | 0 | 0.2 |
| University of Paris-Saclay | University | France | 1 | 1 | 0 | 0 | 0 | 0.2 |
| AstraZeneca | Company | United Kingdom | 2 | 1 | 1 | 0 | 0 | 0.2 |
| SciCross AB | Company | Sweden | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Shanghai Jiao Tong University | University | China | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Sun Yat-sen University | University | China | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Institut National des Sciences Appliquées de Rennes | Institute | France | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Microcomp Nordic AB | Company | Sweden | 1 | 1 | 0 | 0 | 0 | 0.2 |
| National Tsing Hua University | University | Taiwan | 1 | 1 | 0 | 0 | 0 | 0.2 |
| University of Udine | University | Italy | 1 | 0 | 1 | 0 | 0 | 0.2 |
| National Research Council (CNR) | Other Public | Italy | 2 | 1 | 1 | 0 | 0 | 0.2 |
| Novo Nordisk | Company | Denmark | 3 | 0 | 3 | 0 | 0 | 0.2 |
| Ascatron | Company | Sweden | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Inst Natl Sci Appl Rennes | NA | France | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Janssen Pharmaceutica | Company | Belgium | 1 | 1 | 0 | 0 | 0 | 0.1 |
| National Institute of Information and Communications Technology | Institute | Japan | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Södertörns University College | University College | Sweden | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Tokyo Institute of Technology | University | Japan | 1 | 1 | 0 | 0 | 0 | 0.1 |
| United States Navy | Other Public | United States | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Buskerud and Vestfold University College (HBV) | University College | Norway | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Sensonor AS | Company | Norway | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Charles III University of Madrid | University | Spain | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Darmstadt University of Technology | University | Germany | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Farfield Group Ltd | Company | United Kingdom | 1 | 1 | 0 | 0 | 0 | 0.1 |
| microfluidic ChipShop GmbH | Company | Germany | 1 | 1 | 0 | 0 | 0 | 0.1 |
| National Geographic Institute (IGN) | Other Public | Spain | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Q-linea | Company | Sweden | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Swiss Center for Electronics and Microtechnology (CSEM) | Institute | Switzerland | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Tampere University of Technology | University | Finland | 1 | 1 | 0 | 0 | 0 | 0.1 |
| University of Alberta | University | Canada | 1 | 1 | 0 | 0 | 0 | 0.1 |
| University of Valencia | University | Spain | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Italian Institute of Technology (IIT) | Institute | Italy | 1 | 1 | 0 | 0 | 0 | 0.1 |
| MIP Diagnost | NA | United Kingdom | 1 | 1 | 0 | 0 | 0 | 0.1 |
| National Board of Forensic Medicine | Other Public | Sweden | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Optiga AB | Company | Sweden | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Sant’Anna School of Advanced Studies | University | Italy | 1 | 1 | 0 | 0 | 0 | 0.1 |
| University of Mosul | University | Iraq | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Cornell University | University | United States | 2 | 0 | 2 | 0 | 0 | 0.1 |
| Uppsala University Hospital | University Hospital | Sweden | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Taif Univ | University | Saudi Arabia | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Western Sydney Univ | University | Australia | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Boston University | University | United States | 2 | 0 | 2 | 0 | 0 | 0.1 |
| Anhui Polytechnic University (AHPU) | University | China | 1 | 0 | 1 | 0 | 0 | 0.1 |
| East China University of Science and Technology | University | China | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Jiangsu Normal University | University | China | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Oulu | University | Finland | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Danderyds sjukhus | Other health services | Sweden | 1 | 0 | 1 | 0 | 0 | 0.1 |
| ETRA | Company | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| MedTechLabs | NA | Sweden | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Multitel | Institute | Belgium | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Robert Bosch | Company | Germany | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Technical University of Madrid | University | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Seville | University | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Sydney | University | Australia | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Albert Ludwig University of Freiburg | University | Germany | 2 | 0 | 1 | 1 | 0 | 0.1 |
| CFD Res Corp | NA | United States | 2 | 0 | 1 | 1 | 0 | 0.1 |
| University of Lisbon | University | Portugal | 2 | 0 | 1 | 1 | 0 | 0.1 |
| Fractyl Labs Inc | NA | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Stanford University | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Utah | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Yale University | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Ulsan National Institute of Science and Technology UNIST | University | Korea, Republic of | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Wisconsin–Stevens Point (UWSP) | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| King Abdulaziz University (KAU) | University | Saudi Arabia | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Konkuk University | University | Korea, Republic of | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Korea Institute of Science & Technology | Institute | Korea, Republic of | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Northeastern University | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Polytechnic University of Turin | University | Italy | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Applied Sciences and Arts of Western Switzerland | University | Switzerland | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Emulate, Inc. | Company | United States | 2 | 0 | 1 | 1 | 0 | 0.0 |
| Chinese Academy of Sciences | Institute | China | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Duke University | University | United States | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Nanyang Technological University | University | Singapore | 1 | 0 | 1 | 0 | 0 | 0.0 |
| National Taiwan University | University | Taiwan | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Technical University of Denmark (DTU) | University | Denmark | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Technische Universität Dresden | University | Germany | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Tufts University | University | United States | 1 | 0 | 1 | 0 | 0 | 0.0 |
| University of California, Santa Cruz | University | United States | 1 | 0 | 1 | 0 | 0 | 0.0 |
| University of Padova | University | Italy | 1 | 0 | 1 | 0 | 0 | 0.0 |
| University of Pavia | University | Italy | 1 | 0 | 1 | 0 | 0 | 0.0 |
| University of Surrey | University | United Kingdom | 1 | 0 | 1 | 0 | 0 | 0.0 |
| University of Toronto | University | Canada | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) | University College | United States | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Janssen Pharmaceutica | Company | United States | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Jnana Therapeutics | Company | United States | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Lyndra Therapeutics Inc | Company | United States | 1 | 0 | 1 | 0 | 0 | 0.0 |
| All India Institute of Medical Sciences, New Delhi (AIIMS New Delhi) | University Hospital | India | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Government of India | Other Public | India | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Lok Nayak TB And Chest Clinic | Other health services | India | 1 | 0 | 1 | 0 | 0 | 0.0 |
| LRS Institute of Tuberculosis & Respiratory Diseases | Institute | India | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Management Sciences for Health (MSH) | Other health services | United States | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Maulana Azad Medical College (MAMC) | University College | India | 1 | 0 | 1 | 0 | 0 | 0.0 |
| New Delhi Tuberculosis Centre | Other health services | India | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Operation ASHA (OpASHA) | Other health services | India | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Rajan Babu Institute for Pulmonary Medicine and Tuberculosis | Other health services | India | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Safdarjung Hospital (SJ Hospital) | University Hospital | India | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Tata Institute of Fundamental Research (TIFR) | University Other | India | 1 | 0 | 1 | 0 | 0 | 0.0 |
| University of Delaware | University | United States | 1 | 0 | 1 | 0 | 0 | 0.0 |
| GlaxoSmithKline | Company | United States | 1 | 0 | 0 | 1 | 0 | 0.0 |
| Massachusetts General Hospital | University Hospital | United States | 1 | 0 | 0 | 1 | 0 | 0.0 |
| Publication Year | Publications | Open Access publications | OA gold | OA hybrid | OA green | OA bronze | Not OA | Share OA |
|---|---|---|---|---|---|---|---|---|
| 2014 | 24 | 14 | 0 | 0 | 13 | 1 | 10 | 58.3% |
| 2015 | 30 | 15 | 1 | 1 | 13 | 0 | 15 | 50.0% |
| 2016 | 24 | 20 | 3 | 1 | 16 | 0 | 4 | 83.3% |
| 2017 | 43 | 34 | 7 | 1 | 26 | 0 | 9 | 79.1% |
| 2018 | 53 | 32 | 12 | 4 | 15 | 1 | 21 | 60.4% |
| 2019 | 53 | 29 | 5 | 8 | 14 | 2 | 24 | 54.7% |
| 2020 | 46 | 41 | 12 | 14 | 9 | 6 | 5 | 89.1% |
| Total | 273 | 185 | 40 | 29 | 106 | 10 | 88 | 67.8% |
The Open Access type of the publications was fetched from the Unpaywall REST API. The method to determine the OA type is presented here.
In summary, the different OA types can be described as follows:
Gold: The full text has been found on a publisher website, in a journal that is fully OA.
Hybrid: The full text has been found on a publisher website, in a journal that is not fully OA.
Green: The full text has been found in an institutional repository, such as DiVA.
Bronze: The full text has been found on a publisher website but no OA license could be identified.
N.B.: This table is based on peer-reviewed publications for which Unpaywall could determine the OA type (necessary condition: have a DOI number). Unpaywall’s method is empirical and does not strictly equate to copyright license. As a consequence, the OA status of a given publication may vary with time — for example turning from “Not OA” to “Green” when a full text is added to DiVA.
| Publication Year | Publications | Total Citations | Average Citations | Uncited publications | Share uncited |
|---|---|---|---|---|---|
| 2014 | 11.1 | 44.6 | 4.0 | 1.3 | 11.6% |
| 2015 | 12.9 | 230.6 | 17.9 | 3.0 | 23.0% |
| 2016 | 8.5 | 69.6 | 8.1 | 1.8 | 20.5% |
| 2017 | 17.0 | 90.5 | 5.3 | 5.9 | 34.4% |
| 2018 | 22.9 | 154.5 | 6.7 | 9.4 | 41.1% |
| 2019 | 23.5 | 116.8 | 5.0 | 10.6 | 45.3% |
| 2020 | 16.5 | 40.7 | 2.5 | 5.6 | 33.7% |
| Total | 112.4 | 747.3 | 6.6 | 37.5 | 33.3% |
| Publication years | Publications | Average FWCI | Top 10% publications | Share Top 10% |
|---|---|---|---|---|
| 2014-2016 | 28.6 | 1.05 | 2.9 | 10.1% |
| 2015-2017 | 31.1 | 1.19 | 4.3 | 13.8% |
| 2016-2018 | 40.1 | 1.03 | 4.7 | 11.7% |
| 2017-2019 | 53.0 | 1.01 | 6.5 | 12.2% |
| Total | 81.5 | 1.02 | 9.4 | 11.5% |
This table is based on Scopus publication types Article, Review and Conference Paper.
Rows are based on at least 78 (full counted) publications with good Web of Science coverage (at least 96.4%).
(DiVA publication type Article, peer review)
| Publication years | Publications | Average SNIP | Publications in Top 20% journals | Share Top 20% journals |
|---|---|---|---|---|
| 2014-2016 | 23.9 | 1.16 | 9.2 | 38.3% |
| 2015-2017 | 25.5 | 1.15 | 11.1 | 43.6% |
| 2016-2018 | 33.4 | 1.31 | 16.0 | 47.7% |
| 2017-2019 | 44.3 | 1.31 | 22.0 | 49.7% |
| 2018-2020 | 44.9 | 1.41 | 25.1 | 55.9% |
| Total | 80.0 | 1.29 | 38.7 | 48.4% |
| Publication years | Publications | Corporate co-publications | Share corporate | International co-publications | Share international |
|---|---|---|---|---|---|
| 2014-2016 | 84 | 9 | 10.7% | 32 | 38.1% |
| 2015-2017 | 104 | 9 | 8.7% | 41 | 39.4% |
| 2016-2018 | 124 | 12 | 9.7% | 51 | 41.1% |
| 2017-2019 | 155 | 19 | 12.3% | 67 | 43.2% |
| 2018-2020 | 157 | 28 | 17.8% | 80 | 51.0% |
| Total | 289 | 40 | 13.8% | 129 | 44.6% |
This table is based on Scopus publication types Article, Review and Conference Paper.
Rows are based on at least 84 (full counted) publications with good Web of Science coverage (at least 96.2%).
(DiVA publication type Article, peer review)
